Menu

Markets

Research

News

Learn
Paper trading
AI Chat
WatchlistsPortfoliosAlerts
Sign in

GENPF

Genix Pharmaceuticals Corporation

USD

Set alert

Price alert · GENPF

All alert types
0.01 USD 0.00 0.00%
As of Oct 29, 2026
0.0104 Day range 0.0104
0.0104 52-week range 0.03573
YTD
-65.33%
1 year
-40.23%
Open
0.0104
Prev close
0.0104
Mkt cap
636.73K
Vol
259.77K
Avg vol
4.06K
EPS
-0.01
P/E
0.00
More statistics
Low
0.0104
High
0.0104

5D chart

Chart tools
Interval
1m5m15m30m

Chart is warming up

The five-day price history for GENPF has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

-598.59 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

1 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C2 / 5 overall

  • DCF 1
  • Return on Equity 5
  • Return on Assets 1
  • Debt / Equity 1
  • P/E 1
  • P/B 1

Valuation

P/E -4.4×
FY 2016: -58.0×FY 2017: -29.1×FY 2018: 53.7×FY 2019: -44.0×FY 2020: -13.6×FY 2021: -5.3×FY 2022: -0.6×FY 2023: -0.6×FY 2024: -46.4×FY 2025: -4.4×
FY 2016 5y median -4.4× FY 2025
P/S 0.0×
FY 2016: 8.0×FY 2017: 7.0×FY 2018: 17.3×FY 2019: 52.8×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 200×FY 2024: 815×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
P/B -1.0×
FY 2016: 19.2×FY 2017: 58.7×FY 2018: 59.2×FY 2019: -172×FY 2020: 2.0×FY 2021: 2.2×FY 2022: 0.2×FY 2023: -2.2×FY 2024: -2.8×FY 2025: -1.0×
FY 2016 5y median -1.0× FY 2025
P/FCF -11.7×
FY 2016: -44.8×FY 2017: -760×FY 2018: 212×FY 2019: -124×FY 2020: -48.2×FY 2021: -20.5×FY 2022: -2.9×FY 2023: -11.2×FY 2024: -17.6×FY 2025: -11.7×
FY 2016 5y median -11.7× FY 2025
EV/EBITDA -13.8×
FY 2016: -87.5×FY 2017: -240×FY 2018: -300×FY 2019: -44.6×FY 2020: -28.6×FY 2021: -7.8×FY 2022: -1.9×FY 2023: -0.8×FY 2024: 83.7×FY 2025: -13.8×
FY 2016 5y median -1.9× FY 2025
EV/Sales 0.0×
FY 2016: 7.9×FY 2017: 6.9×FY 2018: 17.1×FY 2019: 52.8×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 240×FY 2024: 1013×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
FCF Yield -8.6%
FY 2016: -2.2%FY 2017: -0.1%FY 2018: 0.5%FY 2019: -0.8%FY 2020: -2.1%FY 2021: -4.9%FY 2022: -34.5%FY 2023: -9.0%FY 2024: -5.7%FY 2025: -8.6%
FY 2016 5y median -8.6% FY 2025

Profitability

Gross Margin 0.0%
FY 2016: 44.5%FY 2017: 49.4%FY 2018: 22.1%FY 2019: -33.3%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 26.4%FY 2024: 32.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2016: -15.1%FY 2017: -27.9%FY 2018: -6.2%FY 2019: -104.3%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: -7134.5%FY 2024: -5949.2%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2016: -14.0%FY 2017: -24.1%FY 2018: 31.9%FY 2019: -119.9%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: -35600.3%FY 2024: -1806.9%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
ROE 23.6%
FY 2016: -33.6%FY 2017: -201.0%FY 2018: 109.4%FY 2019: 390.9%FY 2020: -14.8%FY 2021: -41.2%FY 2022: -33.6%FY 2023: 386.5%FY 2024: 6.2%FY 2025: 23.6%
FY 2016 5y median 6.2% FY 2025
ROIC 21.3%
FY 2016: -36.3%FY 2017: -233.4%FY 2018: 114.3%FY 2019: 665.1%FY 2020: -14.3%FY 2021: -40.7%FY 2022: -30.5%FY 2023: 140.8%FY 2024: 65.6%FY 2025: 21.3%
FY 2016 5y median 21.3% FY 2025
ROA -657.2%
FY 2016: -28.5%FY 2017: -61.8%FY 2018: 57.9%FY 2019: -408.9%FY 2020: -13.4%FY 2021: -34.6%FY 2022: -25.3%FY 2023: -1967.0%FY 2024: -160.7%FY 2025: -657.2%
FY 2016 5y median -160.7% FY 2025

Growth (YoY)

Revenue -100.0%
FY 2016: 42.1%FY 2017: 9.3%FY 2018: -58.4%FY 2019: -67.3%FY 2020: -100.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: -67.2%FY 2025: -100.0%
FY 2016 FY 2025
Operating Income 36.4%
FY 2016: 73.6%FY 2017: -102.2%FY 2018: 90.7%FY 2019: -448.6%FY 2020: -399.3%FY 2021: -131.0%FY 2022: 37.6%FY 2023: 14.6%FY 2024: 72.6%FY 2025: 36.4%
FY 2016 FY 2025
EPS (diluted) -366.7%
FY 2016: 78.3%FY 2017: -91.2%FY 2018: 155.4%FY 2019: -222.2%FY 2020: -227.3%FY 2021: -93.8%FY 2022: 35.1%FY 2023: -309.9%FY 2024: 98.4%FY 2025: -366.7%
FY 2016 FY 2025
Free Cash Flow 33.8%
FY 2016: 66.1%FY 2017: 94.3%FY 2018: 465.5%FY 2019: -271.3%FY 2020: -246.8%FY 2021: -111.0%FY 2022: 48.0%FY 2023: 1.0%FY 2024: 15.1%FY 2025: 33.8%
FY 2016 FY 2025

Financial Health

Current Ratio 0.0×
FY 2016: 4.4×FY 2017: 1.1×FY 2018: 2.1×FY 2019: 0.5×FY 2020: 2.0×FY 2021: 0.3×FY 2022: 0.2×FY 2023: 0.2×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.2× FY 2025
Quick Ratio 0.0×
FY 2016: 3.4×FY 2017: 0.7×FY 2018: 1.8×FY 2019: 0.5×FY 2020: 2.0×FY 2021: 0.2×FY 2022: 0.1×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
Debt / Equity -0.5×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: -0.5×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.1×FY 2023: -0.4×FY 2024: -0.7×FY 2025: -0.5×
FY 2016 5y median -0.4× FY 2025
Net Debt / EBITDA -4.3×
FY 2016: 1.3×FY 2017: 3.5×FY 2018: 2.9×FY 2019: 0.1×FY 2020: 2.1×FY 2021: 0.1×FY 2022: -0.4×FY 2023: -0.1×FY 2024: 16.4×FY 2025: -4.3×
FY 2016 5y median -0.1× FY 2025
Interest Coverage -0.9×
FY 2016: -8.6×FY 2017: -17.0×FY 2018: -31.6×FY 2019: -80.6×FY 2020: -184×FY 2021: -471×FY 2022: -85.0×FY 2023: -16.8×FY 2024: -2.0×FY 2025: -0.9×
FY 2016 5y median -16.8× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-10-31